A significant reduction in mortality has been observed in DM/HF patients treated with metformin along with insulin, ACEi and beta blocker therapy (insulin p = 0.002; ACEi p < 0.001; beta-blocker p = 0.017). The gene discussed is INS; the disease is diabetes mellitus.